Relevant to VERIFIED Q2 2026 approved — here is my latest bloodwork comparison:
Key improvements: A1C 7.2% → 5.3%, triglycerides 207 → 107 mg/dL, hsCRP 6.0 → 1.3 mg/L. All on tirzepatide for 11 months.
The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.
Want to share my personal experience related to VERIFIED Q2 2026 approved since I think it might help others in a similar situation.
I started my GLP-1 journey in October 2024 at 248 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.
Now, 6 months later: I am down 83 lbs, my labs have normalized, and I am off 2 of my 3 medications. The VERIFIED Q2 2026 aspect specifically was something that made a big difference in my journey.
This community helped me every step of the way.
I know this thread is old but I found it through search and wanted to add my experience with VERIFIED Q2 2026 approved since this was the most comprehensive discussion I could find.
13 months later, the information in this thread still holds up. My results have been in line with the evidence presented.
For anyone else finding this through search: the advice here is solid. But always verify with your own provider.
Want to share my personal experience related to VERIFIED Q2 2026 approved since I think it might help others in a similar situation.
I started my GLP-1 journey in March 2025 at 265 lbs with metabolic syndrome. My telehealth provider prescribed semaglutide 0.25mg to start.
Now, 12 months later: I am down 35 lbs, my labs have normalized, and my sleep apnea has improved dramatically. The VERIFIED Q2 2026 aspect specifically was something that made a big difference in my journey.
This forum was my go-to resource throughout.
TomTeleRx — that is really helpful context on VERIFIED Q2 2026 approved. Follow-up question: did you change anything about your diet at the same time?
I am in a similar situation (month 2) and trying to set realistic expectations.